Exelixis Net Working Capital vs Common Stock Analysis
EXEL Stock | USD 21.06 0.15 0.72% |
Exelixis financial indicator trend analysis is much more than just examining Exelixis latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Exelixis is a good investment. Please check the relationship between Exelixis Net Working Capital and its Common Stock accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.
Net Working Capital vs Common Stock
Net Working Capital vs Common Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Exelixis Net Working Capital account and Common Stock. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Exelixis' Net Working Capital and Common Stock is -0.22. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Common Stock in the same time period over historical financial statements of Exelixis, assuming nothing else is changed. The correlation between historical values of Exelixis' Net Working Capital and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Exelixis are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Net Working Capital i.e., Exelixis' Net Working Capital and Common Stock go up and down completely randomly.
Correlation Coefficient | -0.22 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Net Working Capital
Common Stock
Most indicators from Exelixis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Exelixis current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.At this time, Exelixis' Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 32.5 M this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.24.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.6B | 1.8B | 1.8B | Total Revenue | 1.4B | 1.6B | 1.8B | 1.9B |
Exelixis fundamental ratios Correlations
Click cells to compare fundamentals
Exelixis Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Exelixis fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.9B | 2.1B | 2.6B | 3.1B | 2.9B | 3.1B | |
Total Stockholder Equity | 1.7B | 1.9B | 2.2B | 2.5B | 2.3B | 2.4B | |
Retained Earnings | (559.4M) | (447.6M) | (216.5M) | (34.2M) | (173.4M) | (182.0M) | |
Common Stock Shares Outstanding | 315.0M | 318.0M | 322.4M | 324.6M | 321.5M | 178.5M | |
Liabilities And Stockholders Equity | 1.9B | 2.1B | 2.6B | 3.1B | 2.9B | 3.1B | |
Other Stockholder Equity | 2.2B | 2.3B | 2.4B | 2.5B | 2.4B | 1.4B | |
Short Long Term Debt Total | 50.7M | 49.1M | 51.3M | 190.2M | 189.9M | 156.7M | |
Other Current Liab | 21.7M | 176.2M | 313.3M | 267.5M | 329.4M | 345.9M | |
Total Current Liabilities | 142.7M | 204.7M | 337.6M | 324.4M | 394.3M | 414.0M | |
Property Plant And Equipment Net | 90.7M | 67.4M | 104.0M | 401.2M | 470.9M | 494.4M | |
Net Debt | (215.8M) | (270.1M) | (595.9M) | (311.0M) | (73.1M) | (69.4M) | |
Accounts Payable | 11.6M | 23.6M | 24.3M | 32.7M | 33.8M | 35.5M | |
Cash | 266.5M | 319.2M | 647.2M | 501.2M | 263.0M | 190.9M | |
Non Current Assets Total | 874.5M | 691.9M | 781.5M | 1.5B | 1.6B | 1.7B | |
Non Currrent Assets Other | 11.3M | 71.9M | 131.0M | 290.6M | 334.2M | 350.9M | |
Cash And Short Term Investments | 852.2M | 1.2B | 1.5B | 1.3B | 995.3M | 1.0B | |
Net Receivables | 119.1M | 160.9M | 282.7M | 214.8M | 237.4M | 249.3M | |
Short Term Investments | 585.7M | 887.3M | 819.9M | 807.3M | 732.3M | 768.9M | |
Non Current Liabilities Total | 57.0M | 53.6M | 68.0M | 258.7M | 284.2M | 213.1M | |
Other Current Assets | 27.0M | 57.0M | 57.5M | 62.2M | 67.9M | 71.3M | |
Total Liab | 199.7M | 258.2M | 405.6M | 583.1M | 678.4M | 370.3M | |
Total Current Assets | 1.0B | 1.4B | 1.8B | 1.6B | 1.3B | 1.4B | |
Accumulated Other Comprehensive Income | 3.1M | 4.5M | (758K) | (14.5M) | (3.8M) | (3.9M) | |
Short Term Debt | 2.7M | 3.0M | 8.7M | 17.7M | 25.7M | 50.4M | |
Common Stock | 305K | 312K | 319K | 324K | 303K | 287.9K | |
Other Liab | 8.9M | 4.5M | 16.8M | 68.5M | 78.8M | 83.4M | |
Other Assets | 185.3M | 187.1M | 197.5M | 286.9M | 329.9M | 346.4M | |
Common Stock Total Equity | 300K | 305K | 312K | 324K | 372.6K | 391.2K | |
Inventory | 12.9M | 21.0M | 27.5M | 33.3M | 17.3M | 9.5M | |
Property Plant And Equipment Gross | 90.7M | 67.4M | 144.9M | 462.1M | 551.2M | 578.8M | |
Property Plant Equipment | 48.9M | 67.4M | 149.2M | 110.6M | 127.2M | 133.6M | |
Current Deferred Revenue | 106.7M | 1.8M | 8.7M | 6.6M | 5.4M | 5.1M | |
Net Tangible Assets | 1.6B | 1.8B | 2.0B | 2.4B | 2.8B | 2.9B | |
Retained Earnings Total Equity | (880.4M) | (559.4M) | (447.6M) | (34.2M) | (39.4M) | (41.3M) | |
Capital Surpluse | 2.2B | 2.2B | 2.3B | 2.5B | 2.9B | 2.1B |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Exelixis using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.Note that the Exelixis information on this page should be used as a complementary analysis to other Exelixis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Exelixis Stock analysis
When running Exelixis' price analysis, check to measure Exelixis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exelixis is operating at the current time. Most of Exelixis' value examination focuses on studying past and present price action to predict the probability of Exelixis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exelixis' price. Additionally, you may evaluate how the addition of Exelixis to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Exelixis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.65 | Revenue Per Share 5.914 | Quarterly Revenue Growth 0.04 | Return On Assets 0.043 | Return On Equity 0.0876 |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.